Elanco Nuplura

Elanco Animal Health Incorporated, Greenfield, Indiana, brings the cattle industry new options for fast, smooth and flexible protection against bovine respiratory disease—one of the deadliest diseases affecting United States cattle. New NUPLURA PH+ builds on the proven performance of NUPLURA PH against Mannheimia haemolytica, while adding protection against common viral causes of BRD, including BVD Types 1 and 2 and IBR.

NUPLURA PH+ provides protective immunity against M. haemolytica in as little as 10 days, which is the fastest immunity claim on the market. For cattle producers concerned about both bacterial and viral causes of BRD, these NUPLURA PH+ options provide additional protection: NUPLURA PH+BVD delivers additional protection against BVD Types 1 and 2; and NUPLURA PH+3 adds protection against BVD Types 1 and 2, plus IBR.

For more information, see a representative or visit www.elanco.com.

TAGS: